Chu-Huang (Mendel) Chen, MD, PhD
See Publications

Texas Heart Institute Positions

Education

  • Postgraduate:

    Texas Tech University

  • Medical School:

    Kaohsiung Medical University, Taiwan

  • Residency:

    Chang-Gung Memorial Hospital, Taiwan (Pathology)
    Maryland General Hospital & Univ. of Maryland (Internal Medicine)

  • Fellowships:

    Baylor College of Medicine

Academic & Clinical Affiliations

Honors, Awards and Memberships

  • The Texas Heart Institute Academic Professional Staff
  • Mentored Outstanding Scholars (Ministry of Science and Technology-Taiwan)2017-2020
  • Editorial board, Kaohsiung Journal of Medical Sciences, 2016–present
  • Outstanding Faculty Teaching Award of China Medical University, 2015
  • Best Clinical Teacher Award of China Medical University Hospital, 2015
  • Outstanding Alumni Award, Kaohsiung Medical University, Taiwan, 2014--life time
  • 12th Generation Chen Style Tai Chi Selected Disciple, 2013–life time
  • Editorial board, Biomedical Journal 2013–present
  • Elite physician of Internal Medicine in China Medical University Hospital, 2013
  • Philip Morris Research Award, 2005–2008
  • Texas Medical Center/NASA Cooperative Research Grant, 1995–1996
  • American Diabetes Association
  • AHA, Atherosclerosis Council
  • International Atherosclerosis Society
  • American Association for the Advancement of Science
  • The Angiogenesis Society

Publications

4862227 IVWSNHMB 1 alternatives-to-animal-experimentation 10 date desc Chen 1863 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22ZWEBTWW7%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kraler%20et%20al.%22%2C%22parsedDate%22%3A%222023-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKraler%2C%20S.%2C%20Wenzl%2C%20F.%20A.%2C%20Vykoukal%2C%20J.%20et%20al.%20%282023%29.%20Low-density%20lipoprotein%20electronegativity%20and%20risk%20of%20death%20after%20acute%20coronary%20syndromes%3A%20A%20case-cohort%20analysis.%20%26lt%3Bi%26gt%3BAtherosclerosis%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B376%26lt%3B%5C%2Fi%26gt%3B%2C%2043%26%23x2013%3B52.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.atherosclerosis.2023.05.014%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.atherosclerosis.2023.05.014%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Low-density%20lipoprotein%20electronegativity%20and%20risk%20of%20death%20after%20acute%20coronary%20syndromes%3A%20A%20case-cohort%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Kraler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florian%20A.%22%2C%22lastName%22%3A%22Wenzl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jody%22%2C%22lastName%22%3A%22Vykoukal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%20F.%22%2C%22lastName%22%3A%22Fahrmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ming-Yi%22%2C%22lastName%22%3A%22Shen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Der-Yuan%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kuan-Cheng%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ching-Kun%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnold%22%2C%22lastName%22%3A%22von%20Eckardstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenz%22%2C%22lastName%22%3A%22R%5Cu00e4ber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Mach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Nanchen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%20M.%22%2C%22lastName%22%3A%22Matter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luca%22%2C%22lastName%22%3A%22Liberale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giovanni%20G.%22%2C%22lastName%22%3A%22Camici%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Akhmedov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chu-Huang%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20F.%22%2C%22lastName%22%3A%22L%5Cu00fcscher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22SPUM-ACS%20investigators%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%20AND%20AIMS%3A%20Low-density%20lipoprotein%20%28LDL%29-cholesterol%20%28LDL-C%29%20promotes%20atherosclerotic%20cardiovascular%20disease%20%28ASCVD%29%2C%20with%20changes%20in%20LDL%20electronegativity%20modulating%20its%20pro-atherogenic%5C%2Fpro-thrombotic%20effects.%20Whether%20such%20alterations%20associate%20with%20adverse%20outcomes%20in%20patients%20with%20acute%20coronary%20syndromes%20%28ACS%29%2C%20a%20patient%20population%20at%20particularly%20high%20cardiovascular%20risk%2C%20remains%20unknown.%5CnMETHODS%3A%20This%20is%20a%20case-cohort%20study%20using%20data%20from%20a%20subset%20of%202619%20ACS%20patients%20prospectively%20recruited%20at%20four%20university%20hospitals%20in%20Switzerland.%20Isolated%20LDL%20was%20chromatographically%20separated%20into%20LDL%20particles%20with%20increasing%20electronegativity%20%28L1-L5%29%2C%20with%20the%20L1-L5%20ratio%20serving%20as%20a%20proxy%20of%20overall%20LDL%20electronegativity.%20Untargeted%20lipidomics%20revealed%20lipid%20species%20enriched%20in%20L1%20%28least%29%20vs.%20L5%20%28most%20electronegative%20subfraction%29.%20Patients%20were%20followed%20at%2030%20days%20and%201%20year.%20The%20mortality%20endpoint%20was%20reviewed%20by%20an%20independent%20clinical%20endpoint%20adjudication%20committee.%20Multivariable-adjusted%20hazard%20ratios%20%28aHR%29%20were%20calculated%20using%20weighted%20Cox%20regression%20models.%5CnRESULTS%3A%20Changes%20in%20LDL%20electronegativity%20were%20associated%20with%20all-cause%20mortality%20at%2030%20days%20%28aHR%2C%202.13%2C%2095%25%20CI%2C%201.07-4.23%20per%201%20SD%20increment%20in%20L1%5C%2FL5%3B%20p%3D.03%29%20and%201%20year%20%281.84%2C%201.03-3.29%3B%20p%3D.04%29%2C%20with%20a%20notable%20association%20with%20cardiovascular%20mortality%20%282.29%3B%201.21-4.35%3B%20p%3D.01%3B%20and%201.88%3B%201.08-3.28%3B%20p%3D.03%29.%20LDL%20electronegativity%20superseded%20several%20risk%20factors%20for%20the%20prediction%20of%201-year%20death%2C%20including%20LDL-C%2C%20and%20conferred%20improved%20discrimination%20when%20added%20to%20the%20updated%20GRACE%20score%20%28area%20under%20the%20receiver%20operating%20characteristic%20curve%200.74%20vs.%200.79%2C%20p%3D.03%29.%20Top%2010%20lipid%20species%20enriched%20in%20L1%20vs.%20L5%20were%3A%20cholesterol%20ester%20%28CE%29%20%2818%3A2%29%2C%20CE%20%2820%3A4%29%2C%20free%20fatty%20acid%20%28FA%29%20%2820%3A4%29%2C%20phosphatidyl-choline%20%28PC%29%20%2836%3A3%29%2C%20PC%20%2834%3A2%29%2C%20PC%20%2838%3A5%29%2C%20PC%20%2836%3A4%29%2C%20PC%20%2834%3A1%29%2C%20triacylglycerol%20%28TG%29%20%2854%3A3%29%2C%20and%20PC%20%2838%3A6%29%20%28all%20p%5Cu00a0%26lt%3B%5Cu00a0.001%29%2C%20with%20CE%20%2818%3A2%29%2C%20CE%20%2820%3A4%29%2C%20PC%20%2836%3A3%29%2C%20PC%20%2834%3A2%29%2C%20PC%20%2838%3A5%29%2C%20PC%20%2836%3A4%29%2C%20TG%20%2854%3A3%29%2C%20and%20PC%20%2838%3A6%29%20independently%20associating%20with%20fatal%20events%20during%201-year%20of%20follow-up%20%28all%20p%5Cu00a0%26lt%3B%5Cu00a0.05%29.%5CnCONCLUSIONS%3A%20Reductions%20in%20LDL%20electronegativity%20are%20linked%20to%20alterations%20of%20the%20LDL%20lipidome%2C%20associate%20with%20all-cause%20and%20cardiovascular%20mortality%20beyond%20established%20risk%20factors%2C%20and%20represent%20a%20novel%20risk%20factor%20for%20adverse%20outcomes%20in%20patients%20with%20ACS.%20These%20associations%20warrant%20further%20validation%20in%20independent%20cohorts.%22%2C%22date%22%3A%222023-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.atherosclerosis.2023.05.014%22%2C%22ISSN%22%3A%221879-1484%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IVWSNHMB%22%2C%22Q46ISS7S%22%5D%2C%22dateModified%22%3A%222023-07-21T18%3A37%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22HA972F5S%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chen%20et%20al.%22%2C%22parsedDate%22%3A%222023-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BChen%26lt%3B%5C%2Fstrong%26gt%3B%2C%20T.-C.%2C%20Hsu%2C%20W.-L.%2C%20Wu%2C%20C.-Y.%20et%20al.%20%282023%29.%20Effect%20of%20omega-6%20linoleic%20acid%20on%20neurobehavioral%20development%20in%20Caenorhabditis%20elegans.%20%26lt%3Bi%26gt%3BProstaglandins%20Leukot%20Essent%20Fatty%20Acids%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B191%26lt%3B%5C%2Fi%26gt%3B%2C%20102557.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.plefa.2023.102557%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.plefa.2023.102557%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Effect%20of%20omega-6%20linoleic%20acid%20on%20neurobehavioral%20development%20in%20Caenorhabditis%20elegans%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tun-Chieh%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wen-Li%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ching-Ying%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yun-Ru%22%2C%22lastName%22%3A%22Lai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22How-Ran%22%2C%22lastName%22%3A%22Chao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chu-Huang%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ming-Hsien%22%2C%22lastName%22%3A%22Tsai%22%7D%5D%2C%22abstractNote%22%3A%22Linoleic%20acid%20%28LA%2C%20omega-6%29%2C%20an%20essential%20polyunsaturated%20fatty%20acid%2C%20is%20supplied%20by%20vegetable%20oils%20such%20as%20corn%2C%20sunflower%20and%20soybean.%20Supplementary%20LA%20in%20infants%20and%20children%20is%20required%20for%20normal%20growth%20and%20brain%20development%2C%20but%20has%20also%20been%20reported%20to%20induce%20brain%20inflammation%20and%20neurodegenerative%20diseases.%20This%20controversial%20role%20of%20LA%20development%20requires%20further%20investigation.%20Our%20study%20utilized%20Caenorhabditis%20elegans%20%28C.%20elegans%29%20as%20a%20model%20to%20clarify%20the%20role%20of%20LA%20in%20regulating%20neurobehavioral%20development.%20A%20mere%20supplementary%20quantity%20of%20LA%20in%20C.%20elegans%20larval%20stage%20affected%20the%20worm%26%23039%3Bs%20locomotive%20ability%2C%20intracellular%20ROS%20accumulation%20and%20lifespan.%20We%20found%20that%20more%20serotonergic%20neurons%20were%20activated%20by%20supplementing%20LA%20above%2010%5Cu00a0%5Cu03bcM%20thereby%20promoting%20locomotive%20ability%20with%20upregulation%20of%20serotonin-related%20genes.%20Supplementation%20with%20LA%20above%2010%5Cu00a0%5Cu03bcM%20also%20inhibited%20the%20expression%20of%20mtl-1%2C%20mtl-2%20and%20ctl-3%20to%20accelerate%20oxidative%20stress%20and%20attenuate%20lifespan%20in%20nematodes%3B%20however%2C%20enhancement%20of%20stress-related%20genes%20such%20as%20sod-1%2C%20sod-3%2C%20mtl-1%2C%20mtl-2%20and%20cyp-35A2%20by%20supplementary%20LA%20under%201%5Cu00a0%5Cu03bcM%20decreased%20oxidative%20stress%20and%20increased%20the%20worm%26%23039%3Bs%20lifespan.%20In%20conclusion%2C%20our%20study%20reveals%20that%20supplementary%20LA%20possesses%20both%20pros%20and%20cons%20in%20worm%20physiology%20and%20provides%20new%20suggestions%20for%20LA%20intake%20administration%20in%20childhood.%22%2C%22date%22%3A%222023-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.plefa.2023.102557%22%2C%22ISSN%22%3A%221532-2823%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IVWSNHMB%22%2C%22BNSCCUCI%22%5D%2C%22dateModified%22%3A%222023-06-08T13%3A52%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22ARZR5KWS%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wu%20et%20al.%22%2C%22parsedDate%22%3A%222023-02-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BWu%2C%20C.-H.%2C%20Hsu%2C%20W.-L.%2C%20Tsai%2C%20C.-C.%20et%20al.%20%282023%29.%207%2C10%2C13%2C16-Docosatetraenoic%20acid%20impairs%20neurobehavioral%20development%20by%20increasing%20reactive%20oxidative%20species%20production%20in%20Caenorhabditis%20elegans.%20%26lt%3Bi%26gt%3BLife%20Sci%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B319%26lt%3B%5C%2Fi%26gt%3B%2C%20121500.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lfs.2023.121500%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lfs.2023.121500%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%227%2C10%2C13%2C16-Docosatetraenoic%20acid%20impairs%20neurobehavioral%20development%20by%20increasing%20reactive%20oxidative%20species%20production%20in%20Caenorhabditis%20elegans%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chia-Hsiu%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wen-Li%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ching-Chung%22%2C%22lastName%22%3A%22Tsai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22How-Ran%22%2C%22lastName%22%3A%22Chao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ching-Ying%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi-Hsuan%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yun-Ru%22%2C%22lastName%22%3A%22Lai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chu-Huang%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ming-Hsien%22%2C%22lastName%22%3A%22Tsai%22%7D%5D%2C%22abstractNote%22%3A%22AIMS%3A%20To%20investigate%20human%20breast%20milk%20%28HBM%29%20lipids%20that%20may%20adversely%20affect%20infant%20neurodevelopment.%5CnMAIN%20METHODS%3A%20We%20performed%20multivariate%20analyses%20that%20combined%20lipidomics%20and%20psychologic%20Bayley-III%20scales%20to%20identify%20which%20HBM%20lipids%20are%20involved%20in%20regulating%20infant%20neurodevelopment.%20We%20observed%20a%20significant%20moderate%20negative%20correlation%20between%207%2C10%2C13%2C16-docosatetraenoic%20acid%20%28omega-6%2C%20C22H36O2%2C%20the%20common%20name%20adrenic%20acid%2C%20AdA%29%20and%20adaptive%20behavioral%20development.%20We%20further%20studied%20the%20effects%20of%20AdA%20on%20neurodevelopment%20by%20using%20Caenorhabditis%20elegans%20%28C.%20elegans%29%20as%20a%20model.%20Worms%20from%20larval%20stages%20L1%20to%20L4%20were%20supplemented%20with%20AdA%20at%205%20nominal%20concentrations%20%280%5Cu00a0%5Cu03bcM%20%5Bcontrol%5D%2C%200.1%5Cu00a0%5Cu03bcM%2C%201%5Cu00a0%5Cu03bcM%2C%2010%5Cu00a0%5Cu03bcM%2C%20and%20100%5Cu00a0%5Cu03bcM%29%20and%20subjected%20to%20behavioral%20and%20mechanistic%20analyses.%5CnKEY%20FINDINGS%3A%20Supplementation%20with%20AdA%20from%20larval%20stages%20L1%20to%20L4%20impaired%20neurobehavioral%20development%2C%20such%20as%20locomotive%20behaviors%2C%20foraging%20ability%2C%20chemotaxis%20behavior%2C%20and%20aggregation%20behavior.%20Furthermore%2C%20AdA%20upregulated%20the%20production%20of%20intracellular%20reactive%20oxygen%20species.%20AdA-induced%20oxidative%20stress%20blocked%20serotonin%20synthesis%20and%20serotoninergic%20neuron%20activity%20and%20inhibited%20expression%20of%20daf-16%20and%20the%20daf-16-regulated%20genes%20mtl-1%2C%20mtl-2%2C%20sod-1%2C%20and%20sod-3%2C%20resulting%20in%20attenuation%20of%20the%20lifespan%20in%20C.%20elegans.%5CnSIGNIFICANCE%3A%20Our%20study%20reveals%20that%20AdA%20is%20a%20harmful%20HBM%20lipid%20that%20may%20have%20adverse%20effects%20on%20infant%20adaptive%20behavioral%20development.%20We%20believe%20this%20information%20may%20be%20critical%20for%20AdA%20administration%20guidance%20in%20children%26%23039%3Bs%20health%20care.%22%2C%22date%22%3A%22Feb%2015%2C%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.lfs.2023.121500%22%2C%22ISSN%22%3A%221879-0631%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IVWSNHMB%22%2C%22JD5ZU4IS%22%5D%2C%22dateModified%22%3A%222023-03-14T14%3A33%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22CT764MJ8%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hosomi%20et%20al.%22%2C%22parsedDate%22%3A%222022-10-21%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHosomi%2C%20K.%2C%20Kawashima%2C%20H.%2C%20Nakano%2C%20A.%20et%20al.%20%282022%29.%20NanoSPECT%20imaging%20reveals%20the%20uptake%20of%20123I-labeled%20oxidized%20low-density%20lipoprotein%20in%20the%20brown%20adipose%20tissue%20of%20mice%20via%20CD36.%20%26lt%3Bi%26gt%3BCardiovasc%20Res%26lt%3B%5C%2Fi%26gt%3B%2C%20cvac167.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcvr%5C%2Fcvac167%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcvr%5C%2Fcvac167%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22NanoSPECT%20imaging%20reveals%20the%20uptake%20of%20123I-labeled%20oxidized%20low-density%20lipoprotein%20in%20the%20brown%20adipose%20tissue%20of%20mice%20via%20CD36%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kento%22%2C%22lastName%22%3A%22Hosomi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hidekazu%22%2C%22lastName%22%3A%22Kawashima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Atsushi%22%2C%22lastName%22%3A%22Nakano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akemi%22%2C%22lastName%22%3A%22Kakino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuko%22%2C%22lastName%22%3A%22Okamatsu-Ogura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Yamashita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mai%22%2C%22lastName%22%3A%22Sasaoka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisaku%22%2C%22lastName%22%3A%22Masuda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shizuya%22%2C%22lastName%22%3A%22Yamashita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chu-Huang%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shunsuke%22%2C%22lastName%22%3A%22Yuzuriha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroshi%22%2C%22lastName%22%3A%22Hosoda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hidehiro%22%2C%22lastName%22%3A%22Iida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tatsuya%22%2C%22lastName%22%3A%22Sawamura%22%7D%5D%2C%22abstractNote%22%3A%22AIMS%3A%20The%20liver%20is%20the%20major%20organ%20shown%20to%20remove%20oxidized%20low-density%20lipoprotein%20%28oxLDL%29%20from%20the%20circulation.%20Given%20increased%20evidence%20that%20thermogenic%20adipose%20tissue%20has%20anti-atherogenic%20effects%2C%20we%20used%20123I-labeled%20oxLDL%20as%20a%20tracer%20to%20reveal%20oxLDL%20accumulation%20in%20the%20brown%20adipose%20tissue%20%28BAT%29%20of%20mice.%20We%20also%20explored%20the%20mechanisms%20of%20oxLDL%20accumulation%20in%20BAT.%5CnMETHODS%20AND%20RESULTS%3A%20We%20used%20high-resolution%20nanoSPECT%5C%2FCT%20to%20investigate%20the%20tissue%20distribution%20of%20123I-oxLDL%20and%20123I-LDL%20%28control%29%20following%20intravenous%20injection%20into%20conscious%20mice.%20123I-oxLDL%20distribution%20was%20discovered%20in%20BAT%20at%20an%20intensity%20equivalent%20to%20that%20in%20the%20liver%2C%20whereas%20123I-LDL%20was%20detected%20mostly%20in%20the%20liver.%20Consistent%20with%20the%20function%20of%20BAT%20related%20to%20sympathetic%20nerve%20activity%2C%20administering%20anesthesia%20in%20mice%20almost%20completely%20eliminated%20the%20accumulation%20of%20123I-oxLDL%20in%20BAT%2C%20and%20this%20effect%20was%20reversed%20by%20administering%20%5Cu03b23-agonist.%20Furthermore%2C%20exposing%20mice%20to%20cold%20stress%20at%204%20%5Cu00b0C%20enhanced%20123I-oxLDL%20accumulation%20in%20BAT.%20Because%20in%20123I-oxLDL%2C%20the%20protein%20of%20oxLDL%20was%20labeled%2C%20we%20performed%20additional%20experiments%20with%20DiI-oxLDL%20in%20which%20the%20lipid%20phase%20of%20oxLDL%20was%20fluorescently%20labeled%20and%20observed%20similar%20results%2C%20suggesting%20that%20the%20whole%20oxLDL%20particle%20was%20taken%20up%20by%20BAT.%20To%20identify%20the%20receptor%20responsible%20for%20oxLDL%20uptake%20in%20BAT%2C%20we%20analyzed%20the%20expression%20of%20known%20oxLDL%20receptors%20%28e.g.%2C%20SR-A%2C%20CD36%2C%20LOX-1%29%20in%20cultured%20brown%20adipocyte%20cell%20line%20and%20primary%20brown%20adipocytes%20and%20found%20that%20CD36%20was%20the%20major%20receptor%20expressed.%20Treatment%20of%20cells%20with%20CD36%20siRNA%20or%20CD36%20neutralizing%20antibody%20significantly%20inhibited%20DiI-oxLDL%20uptake.%20Finally%2C%20CD36%20deletion%20in%20mice%20abolished%20the%20accumulation%20of%20123I-oxLDL%20and%20DiI-oxLDL%20in%20BAT%2C%20indicating%20that%20CD36%20is%20the%20major%20receptor%20for%20oxLDL%20in%20BAT.%5CnCONCLUSION%3A%20We%20show%20novel%20evidence%20for%20the%20CD36-mediated%20accumulation%20of%20oxLDL%20in%20BAT%2C%20suggesting%20that%20BAT%20may%20exert%20its%20anti-atherogenic%20effects%20by%20removing%20atherogenic%20LDL%20from%20the%20circulation.%22%2C%22date%22%3A%22Oct%2021%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcvr%5C%2Fcvac167%22%2C%22ISSN%22%3A%221755-3245%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IVWSNHMB%22%2C%22QF52JASW%22%5D%2C%22dateModified%22%3A%222022-12-01T19%3A18%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22RJMTKIS3%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chang%20et%20al.%22%2C%22parsedDate%22%3A%222022-10-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChang%2C%20C.-K.%2C%20Chang%2C%20K.-H.%2C%20%26lt%3Bstrong%26gt%3BChen%26lt%3B%5C%2Fstrong%26gt%3Bg%2C%20W.-C.%20et%20al.%20%282022%29.%20Lipid%20metabolomic%20signature%20might%20predict%20subclinical%20atherosclerosis%20in%20patients%20with%20active%20rheumatoid%20arthritis.%20%26lt%3Bi%26gt%3BClin%20Exp%20Rheumatol%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.55563%5C%2Fclinexprheumatol%5C%2Fint08c%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.55563%5C%2Fclinexprheumatol%5C%2Fint08c%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lipid%20metabolomic%20signature%20might%20predict%20subclinical%20atherosclerosis%20in%20patients%20with%20active%20rheumatoid%20arthritis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ching-Kun%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kuang-Hsi%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei-Chung%22%2C%22lastName%22%3A%22Cheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Po-Ku%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22En-Pei%20Isabel%22%2C%22lastName%22%3A%22Chiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shih-Hsin%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi-Chen%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chu-Huang%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Der-Yuan%22%2C%22lastName%22%3A%22Chen%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20Although%201H-nuclear%20magnetic%20resonance%20%28NMR%29-based%20lipid%5C%2Fmetabolomics%20has%20been%20used%20to%20detect%20atherosclerosis%2C%20data%20regarding%20lipid%5C%2Fmetabolomic%20signature%20in%20rheumatoid%20arthritis%20%28RA%29-related%20atherosclerosis%20are%20scarce.%20We%20aimed%20to%20identify%20the%20distinct%20lipid%5C%2Fmetabolomic%20profiling%20and%20develop%20a%20prediction%20score%20model%20for%20RA%20patients%20with%20subclinical%20atherosclerosis%20%28SA%29.%5CnMETHODS%3A%20Serum%20levels%20of%20lipid%20metabolites%20were%20determined%20using%201H-NMR-based%20lipid%5C%2Fmetabolomics%20in%2065%20RA%20patients%20and%2012%20healthy%20controls%20%28HCs%29.%20The%20occurrence%20of%20SA%20was%20defined%20as%20the%20presence%20of%20carotid%20plaques%20revealed%20in%20ultrasound%20images.%5CnRESULTS%3A%20Compared%20with%20HC%2C%20RA%20patients%20had%20significantly%20higher%20levels%20of%20phenylalanine%20and%20glycoprotein%20acetyls%20%28GlycA%29%20and%20lower%20levels%20of%20leucine%20and%20isoleucine.%20RA%20patients%20with%20SA%20had%20significantly%20higher%20levels%20of%20phenylalanine%2C%20creatinine%2C%20and%20glycolysis_total%20and%20lower%20levels%20of%20total%20lipid%20in%20HDL%28HDL_L%29%20than%20RA%20patients%20without%20SA.%20The%20Lasso%20logistic%20regression%20analysis%20revealed%20that%20age%2C%20creatinine%2C%20HDL_L%2C%20and%20glycolysis_total%20were%20significant%20predictors%20for%20the%20presence%20of%20SA.%20The%20prediction%20scoring%20algorithm%20was%20built%20as%20%28%20-0.657%20%2B%200.011%2AAge%20%2B%200.004%2ACreatinine%20-0.120%2AHDL_L%20%2B%200.056%2Aglycolysis-related%20measures%29%2C%20with%20AUC%200.90%2C%20sensitivity%2083.3%25%2C%20and%20specificity%2087.2%25.%20Serum%20phenylalanine%20levels%20were%20significantly%20decreased%2C%20and%20the%20levels%20of%20HDL_L%20and%20HDL_Particle%20were%20significantly%20increased%20in%2020%20RA%20patients%2C%20paralleling%20the%20decrease%20in%20disease%20activity%20score%20for%2028-joints.%5CnCONCLUSIONS%3A%20With%201H-NMR-based%20lipid%5C%2Fmetabolomics%2C%20distinct%20profiling%20of%20lipid%20metabolites%20was%20identified%20between%20RA%20patients%20and%20HC%20or%20between%20RA%20patients%20with%20and%20without%20SA.%20We%20further%20developed%20a%20scoring%20model%20based%20on%20lipid%5C%2Fmetabolomics%20profiling%20for%20predicting%20RA-associated%20SA.%22%2C%22date%22%3A%22Oct%2004%2C%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.55563%5C%2Fclinexprheumatol%5C%2Fint08c%22%2C%22ISSN%22%3A%220392-856X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IVWSNHMB%22%2C%22MDTREPAF%22%5D%2C%22dateModified%22%3A%222022-11-04T15%3A25%3A31Z%22%7D%7D%2C%7B%22key%22%3A%22YKKV92QB%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lee%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLee%2C%20H.-C.%2C%20Akhmedov%2C%20A.%20and%20%26lt%3Bstrong%26gt%3BChen%26lt%3B%5C%2Fstrong%26gt%3B%2C%20C.-H.%20%282022%29.%20Spotlight%20on%20very-low-density%20lipoprotein%20as%20a%20driver%20of%20cardiometabolic%20disorders%3A%20Implications%20for%20disease%20progression%20and%20mechanistic%20insights.%20%26lt%3Bi%26gt%3BFront%20Cardiovasc%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B9%26lt%3B%5C%2Fi%26gt%3B%2C%20993633.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffcvm.2022.993633%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffcvm.2022.993633%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Spotlight%20on%20very-low-density%20lipoprotein%20as%20a%20driver%20of%20cardiometabolic%20disorders%3A%20Implications%20for%20disease%20progression%20and%20mechanistic%20insights%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hsiang-Chun%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Akhmedov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chu-Huang%22%2C%22lastName%22%3A%22Chen%22%7D%5D%2C%22abstractNote%22%3A%22Very-low-density%20lipoprotein%20%28VLDL%29%20is%20the%20only%20lipoprotein%20containing%20apolipoprotein%20B%20that%20is%20secreted%20from%20the%20liver%2C%20where%20VLDL%20is%20assembled%20from%20apolipoproteins%2C%20cholesterol%2C%20and%20triglycerides.%20The%20primary%20function%20of%20VLDL%20is%20to%20transport%20cholesterol%20and%20other%20lipids%20to%20organs%20and%20cells%20for%20utilization.%20Apart%20from%20its%20role%20in%20normal%20biologic%20processes%2C%20VLDL%20is%20also%20known%20to%20contribute%20to%20the%20development%20of%20atherosclerotic%20cardiovascular%20disease.%20Large%20VLDL%20particles%2C%20which%20are%20subclassified%20according%20to%20their%20size%20by%20nuclear%20magnetic%20resonance%20spectrometry%2C%20are%20significantly%20correlated%20not%20only%20with%20atherosclerosis%2C%20but%20also%20with%20insulin%20resistance%20and%20diabetes%20incidence.%20VLDL%20can%20also%20be%20subclassified%20according%20to%20surface%20electrical%20charge%20by%20using%20anion-exchange%20chromatography.%20The%20most%20electronegative%20VLDL%20subclass%20is%20highly%20cytotoxic%20to%20endothelial%20cells%20and%20may%20contribute%20to%20coronary%20heart%20disease.%20In%20addition%2C%20electronegative%20VLDL%20contributes%20to%20the%20development%20of%20atrial%20remodeling%2C%20especially%20in%20patients%20with%20metabolic%20syndrome%2C%20which%20is%20an%20established%20risk%20factor%20for%20atrial%20fibrillation.%20In%20this%20review%2C%20we%20focus%20on%20the%20VLDL%20subclasses%20that%20are%20associated%20with%20apolipoprotein%20alterations%20and%20are%20involved%20in%20cardiometabolic%20disease.%20The%20postprandial%20enhancement%20of%20VLDL%26%23039%3Bs%20pathogenicity%20is%20a%20critical%20medical%20issue%2C%20especially%20in%20patients%20with%20metabolic%20syndrome.%20Therefore%2C%20the%20significance%20of%20the%20postprandial%20modification%20of%20VLDL%26%23039%3Bs%20chemical%20and%20functional%20properties%20is%20extensively%20discussed.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffcvm.2022.993633%22%2C%22ISSN%22%3A%222297-055X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IVWSNHMB%22%2C%22MDTREPAF%22%5D%2C%22dateModified%22%3A%222022-10-31T19%3A59%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22WHKCSWD8%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lin%20et%20al.%22%2C%22parsedDate%22%3A%222021-12-02%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLin%2C%20K.-C.%2C%20Ting%2C%20L.-L.%2C%20Chang%2C%20C.-L.%20et%20al.%20%282021%29.%20Ex%20vivo%20expanded%20circulating%20tumor%20cells%20for%20clinical%20anti-cancer%20drug%20prediction%20in%20patients%20with%20head%20and%20neck%20cancer.%20%26lt%3Bi%26gt%3BCancers%20%28Basel%29%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B13%26lt%3B%5C%2Fi%26gt%3B%2C%206076.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcancers13236076%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcancers13236076%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Ex%20vivo%20expanded%20circulating%20tumor%20cells%20for%20clinical%20anti-cancer%20drug%20prediction%20in%20patients%20with%20head%20and%20neck%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kuan-Chou%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lai-Lei%22%2C%22lastName%22%3A%22Ting%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chia-Lun%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Long-Sheng%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hsin-Lun%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fang-Chi%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeng-Fong%22%2C%22lastName%22%3A%22Chiou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng-Yuan%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thierry%22%2C%22lastName%22%3A%22Burnouf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dennis%20Chun-Yu%22%2C%22lastName%22%3A%22Ho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai-Chiang%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chang-Yu%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chu-Huang%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ching-Zong%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yin-Ju%22%2C%22lastName%22%3A%22Chen%22%7D%5D%2C%22abstractNote%22%3A%22The%20advanced-stage%20head%20and%20neck%20cancer%20%28HNC%29%20patients%20respond%20poorly%20to%20platinum-based%20treatments.%20Thus%2C%20a%20reliable%20pretreatment%20method%20for%20evaluating%20platinum%20treatment%20response%20would%20improve%20therapeutic%20efficiency%20and%20outcomes.%20This%20study%20describes%20a%20novel%20strategy%20to%20predict%20clinical%20drug%20responses%20in%20HNC%20patients%20by%20using%20eSelect%2C%20a%20lab-developed%20biomimetic%20cell%20culture%20system%2C%20which%20enables%20us%20to%20perform%20ex%20vivo%20expansion%20and%20drug%20sensitivity%20profiling%20of%20circulating%20tumor%20cells%20%28CTCs%29.%20Forty%20liquid%20biopsies%20were%20collected%20from%20HNC%20patients%2C%20and%20the%20CTCs%20were%20expanded%20ex%20vivo%20using%20the%20eSelect%20system%20within%20four%20weeks.%20Immunofluorescence%20staining%20confirmed%20that%20the%20CTC-derived%20organoids%20were%20positive%20for%20EpCAM%20and%20negative%20for%20CD45.%20Two%20illustrative%20cases%20present%20the%20potential%20of%20this%20strategy%20for%20evaluating%20treatment%20response.%20The%20statistical%20analysis%20confirmed%20that%20drug%20sensitivity%20in%20CTC-derived%20organoids%20was%20associated%20with%20a%20clinical%20response.%20The%20multivariant%20logistic%20regression%20model%20predicted%20that%20the%20treatment%20accuracy%20of%20chemotherapy%20responses%20achieved%2093.75%25%2C%20and%20the%20area%20under%20the%20curves%20%28AUCs%29%20of%20prediction%20models%20was%200.8841%20in%20the%20whole%20dataset%20and%200.9167%20in%20cisplatin%20specific%20dataset.%20In%20summary%2C%20cisplatin%20sensitivity%20profiles%20of%20patient-derived%20CTCs%20expanded%20ex%20vivo%20correlate%20with%20a%20clinical%20response%20to%20cisplatin%20treatment%2C%20and%20this%20can%20potentially%20underpin%20predictive%20assays%20to%20guide%20HNC%20treatments.%22%2C%22date%22%3A%22Dec%202%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fcancers13236076%22%2C%22ISSN%22%3A%222072-6694%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IVWSNHMB%22%2C%22AUPQENLZ%22%5D%2C%22dateModified%22%3A%222022-01-07T19%3A59%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22FFAAV68A%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tsai%20et%20al.%22%2C%22parsedDate%22%3A%222021-11-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BTsai%2C%20M.-H.%2C%20Chao%2C%20H.-R.%2C%20Hsu%2C%20W.-L.%20et%20al.%20%282021%29.%20Analysis%20of%20polybrominated%20diphenyl%20ethers%20and%20lipid%20composition%20in%20human%20breast%20milk%20and%20their%20correlation%20with%20infant%20neurodevelopment.%20%26lt%3Bi%26gt%3BInt%20J%20Environ%20Res%20Public%20Health%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B18%26lt%3B%5C%2Fi%26gt%3B%2C%2011501.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijerph182111501%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijerph182111501%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Analysis%20of%20polybrominated%20diphenyl%20ethers%20and%20lipid%20composition%20in%20human%20breast%20milk%20and%20their%20correlation%20with%20infant%20neurodevelopment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ming-Hsien%22%2C%22lastName%22%3A%22Tsai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22How-Ran%22%2C%22lastName%22%3A%22Chao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wen-Li%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ching-Chung%22%2C%22lastName%22%3A%22Tsai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chu-Wen%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chu-Huang%22%2C%22lastName%22%3A%22Chen%22%7D%5D%2C%22abstractNote%22%3A%22Breastfeeding%20is%20recommended%20over%20formula%20feeding%2C%20but%20human%20breast%20milk%20%28HBM%29%20composition%20varies%20and%20can%20be%20affected%20by%20food%20additives.%20Whether%20flame-retardant%20polybrominated%20diphenyl%20ethers%20%28PBDEs%29%20found%20in%20HBM%20interact%20with%20lipid%20components%20of%20HBM%20to%20impede%20infant%20neurodevelopment%20is%20a%20critical%20public%20health%20issue.%20Using%20lipidomic%20analysis%2C%20we%20examined%20the%20association%20of%20PBDEs%20in%20HBM%20and%20HBM%20lipid%20components%20with%20infant%20neurodevelopment.%20HBM%20samples%20%28n%20%3D%20100%29%20were%20collected%20at%20the%20beginning%20stage%20of%20breastfeeding%20and%20analyzed%20for%2030%20PBDE%20congeners%20as%20well%20as%20a%20group%20of%20lipid%20components%20by%20using%20high-resolution%20gas%20chromatography%2C%20mass%20spectrometry%2C%20and%20liquid%20chromatography%20time-of-flight%20mass%20spectrometry.%20Infants%20were%20examined%20at%208%20to%2012%20months%20of%20age%20by%20using%20the%20Bayley-III%20to%20assess%20neurodevelopment.%20A%20total%20of%20seven%20PBDEs%2C%2035%20lipids%2C%20and%2027%20fatty%20acids%20in%20HBM%20showed%20significant%20associations%20with%20Bayley-III%20scores.%20Multivariate%20analysis%20confirmed%20that%20these%20candidate%20PBDEs%20and%20lipid%20components%20were%20significant%20predictors%20of%20infant%20neurodevelopment.%20Eicosapentaenoic%20acid%20and%20docosapentaenoic%20acid%20in%20HBM%20showed%20no%20association%20with%20infant%20neurodevelopment%20in%20the%20general%20Taiwanese%20population.%20While%20certain%20PBDEs%20may%20play%20a%20role%2C%20our%20findings%20indicate%20that%20the%20lipid%20components%20of%20HBM%20are%20directly%20important%20for%20infant%20neurodevelopment.%22%2C%22date%22%3A%22Nov%2011%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fijerph182111501%22%2C%22ISSN%22%3A%221660-4601%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IVWSNHMB%22%5D%2C%22dateModified%22%3A%222021-12-06T20%3A45%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22IKRRX545%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chang%20et%20al.%22%2C%22parsedDate%22%3A%222021-10-22%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChang%2C%20C.-K.%2C%20%26lt%3Bstrong%26gt%3BChen%26lt%3B%5C%2Fstrong%26gt%3Bg%2C%20W.-C.%2C%20Ma%2C%20W.-L.%20et%20al.%20%282021%29.%20The%20potential%20role%20of%20electronegative%20high-density%20lipoprotein%20H5%20subfraction%20in%20RA-related%20atherosclerosis.%20%26lt%3Bi%26gt%3BInt%20J%20Mol%20Sci%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B22%26lt%3B%5C%2Fi%26gt%3B%2C%2011419.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijms222111419%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijms222111419%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20potential%20role%20of%20electronegative%20high-density%20lipoprotein%20H5%20subfraction%20in%20RA-related%20atherosclerosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ching-Kun%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei-Chung%22%2C%22lastName%22%3A%22Cheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wen-Lung%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Po-Ku%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chu-Huang%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pei-Chun%22%2C%22lastName%22%3A%22Shen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chia-Ching%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shih-Hsin%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi-Hua%22%2C%22lastName%22%3A%22Lai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Der-Yuan%22%2C%22lastName%22%3A%22Chen%22%7D%5D%2C%22abstractNote%22%3A%22Although%20the%20heterogeneity%20of%20high-density%20lipoprotein-cholesterol%20%28HDL-c%29%20composition%20is%20associated%20with%20atherosclerotic%20cardiovascular%20risk%2C%20the%20link%20between%20electronegative%20subfractions%20of%20HDL-c%20and%20atherosclerosis%20in%20rheumatoid%20arthritis%20%28RA%29%20remains%20unknown.%20We%20examined%20the%20association%20of%20the%20percentage%20of%20the%20most%20electronegative%20subfraction%20of%20HDL-c%20%28H5%25%29%20and%20RA-related%20atherosclerosis.%20Using%20anion-exchange%20purification%5C%2Ffast-protein%20liquid%20chromatography%2C%20we%20demonstrated%20significantly%20higher%20H5%25%20in%20patients%20%28median%2C%207.2%25%29%20than%20HC%20%282.8%25%2C%20p%20%26lt%3B%200.005%29.%20Multivariable%20regression%20analysis%20revealed%20H5%25%20as%20a%20significant%20predictor%20for%20subclinical%20atherosclerosis.%20We%20subsequently%20explored%20atherogenic%20role%20of%20H5%20using%20cell-based%20assay.%20The%20results%20showed%20significantly%20higher%20levels%20of%20IL-1%5Cu03b2%20and%20IL-8%20mRNA%20in%20H5-treated%20%28mean%20%5Cu00b1%20SD%2C%204.45%20%5Cu00b1%201.22%20folds%2C%206.02%20%5Cu00b1%201.43-folds%2C%20respectively%29%20than%20H1-treated%20monocytes%20%280.89%20%5Cu00b1%200.18-folds%2C%201.03%20%5Cu00b1%200.26-folds%2C%20respectively%2C%20both%20p%20%26lt%3B%200.001%29.%20In%20macrophages%2C%20H5%20upregulated%20the%20mRNA%20and%20protein%20expression%20of%20IL-1%5Cu03b2%20and%20IL-8%20in%20a%20dose-dependent%20manner%2C%20and%20their%20expression%20levels%20were%20significantly%20higher%20than%20H1-treated%20macrophages%20%28all%20p%20%26lt%3B%200.001%29.%20H5%20induced%20more%20foam%20cell%20formation%20compared%20with%20H1-treated%20macrophages%20%28p%20%26lt%3B%200.005%29.%20In%20addition%2C%20H5%20has%20significantly%20lower%20cholesterol%20efflux%20capacity%20than%20H1%20%28p%20%26lt%3B%200.005%29.%20The%20results%20of%20nanoLC-MS%5C%2FMS%20approach%20reveal%20that%20the%20best%20discriminator%20between%20high-H5%25%20and%20normal-H5%25%20is%20Apo%28a%29%2C%20the%20main%20constituent%20of%20Lp%28a%29.%20Moreover%2C%20Lp%28a%29%20level%20is%20a%20significant%20predictor%20for%20high-H5%25.%20These%20observations%20suggest%20that%20H5%20is%20involved%20in%20RA-related%20atherosclerosis.%22%2C%22date%22%3A%22Oct%2022%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fijms222111419%22%2C%22ISSN%22%3A%221422-0067%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IVWSNHMB%22%5D%2C%22dateModified%22%3A%222021-12-06T20%3A44%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22BA2P7KS8%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chang%20et%20al.%22%2C%22parsedDate%22%3A%222021-08-30%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChang%2C%20C.-K.%2C%20%26lt%3Bstrong%26gt%3BChen%26lt%3B%5C%2Fstrong%26gt%3B%2C%20P.-K.%2C%20%26lt%3Bstrong%26gt%3BChen%26lt%3B%5C%2Fstrong%26gt%3B%2C%20C.-C.%20et%20al.%20%282021%29.%20Increased%20levels%20of%20omega-3%20fatty%20acids%20and%20DHA%20are%20linked%20to%20pain%20reduction%20in%20rheumatoid%20arthritis%20patients%20treated%20with%20Janus%20kinase%20inhibitors.%20%26lt%3Bi%26gt%3BNutrients%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B13%26lt%3B%5C%2Fi%26gt%3B%2C%203050.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fnu13093050%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fnu13093050%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Increased%20levels%20of%20omega-3%20fatty%20acids%20and%20DHA%20are%20linked%20to%20pain%20reduction%20in%20rheumatoid%20arthritis%20patients%20treated%20with%20Janus%20kinase%20inhibitors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ching-Kun%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Po-Ku%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chia-Ching%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shih-Hsin%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chu-Huang%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Der-Yuan%22%2C%22lastName%22%3A%22Chen%22%7D%5D%2C%22abstractNote%22%3A%22Although%20Janus%20kinase%20inhibitors%20%28JAKi%29%20could%20reduce%20patient-reported%20pain%20in%20rheumatoid%20arthritis%20%28RA%29%2C%20their%20mechanism%20remains%20unclear.%20Therefore%2C%20we%20examined%20lipid%20metabolites%20change%20in%20JAKi-treated%20patients%20and%20evaluate%20their%20association%20with%20pain%20reduction.%20We%20used%201H-NMR-based%20lipid%5C%2Fmetabolomics%20to%20determine%20serum%20levels%20of%20lipid%20metabolites%20at%20baseline%20and%20week%2024%20of%20treatment.%20Serum%20levels%20of%20significant%20lipid%20metabolites%20were%20replicated%20by%20ELISA%20in%2024%20JAKi-treated%20and%2012%20tocilizumab-treated%20patients.%20Pain%20was%20evaluated%20with%20patients%26%23039%3B%20assessment%20on%20a%200-100%20mm%20VAS%2C%20and%20disease%20activity%20assessed%20using%20DAS28.%20JAKi%20or%20tocilizumab%20therapy%20significantly%20reduced%20disease%20activity.%20Acceptable%20pain%20%28VAS%20pain%20%5Cu226420%29%20at%20week%2024%20was%20observed%20in%2066.7%25%20of%20JAKi-treated%20patients%2C%20and%20pain%20decrement%20was%20greater%20than%20tocilizumab-treated%20patients%20%28%5Cu0394VAS%20pain%2070.0%20vs.%2052.5%2C%20p%20%3D%200.0595%29.%20Levels%20of%20omega-3%20fatty%20acids%20and%20docosahexaenoic%20acid%20%28DHA%29%20were%20increased%20in%20JAKi-treated%20patients%20%28median%200.55%20mmol%5C%2FL%20versus%200.71%20mmol%5C%2FL%2C%20p%20%3D%200.0005%3B%200.29%20mmol%5C%2FL%20versus%200.35%20mmol%5C%2FL%2C%20p%20%3D%200.0004%3B%20respectively%29%2C%20which%20were%20not%20observed%20in%20tocilizumab-treated%20patients.%20ELISA%20results%20showed%20increased%20DHA%20levels%20in%20JAKi-treated%20patients%20with%20acceptable%20pain%20%2844.30%20%5Cu00b5g%5C%2FmL%20versus%2045.61%20%5Cu00b5g%5C%2FmL%2C%20p%20%3D%200.028%29.%20A%20significant%20association%20of%20pain%20decrement%20with%20DHA%20change%2C%20not%20with%20DAS28%20change%2C%20was%20seen%20in%20JAKi-treated%20patients.%20The%20pain%20reduction%20effect%20of%20JAKi%20probably%20links%20to%20increased%20levels%20of%20omega-3%20fatty%20acids%20and%20DHA.%22%2C%22date%22%3A%22Aug%2030%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fnu13093050%22%2C%22ISSN%22%3A%222072-6643%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IVWSNHMB%22%5D%2C%22dateModified%22%3A%222021-10-07T18%3A21%3A47Z%22%7D%7D%5D%7D
Kraler, S., Wenzl, F. A., Vykoukal, J. et al. (2023). Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis. Atherosclerosis 376, 43–52. https://doi.org/10.1016/j.atherosclerosis.2023.05.014.
Chen, T.-C., Hsu, W.-L., Wu, C.-Y. et al. (2023). Effect of omega-6 linoleic acid on neurobehavioral development in Caenorhabditis elegans. Prostaglandins Leukot Essent Fatty Acids 191, 102557. https://doi.org/10.1016/j.plefa.2023.102557.
Wu, C.-H., Hsu, W.-L., Tsai, C.-C. et al. (2023). 7,10,13,16-Docosatetraenoic acid impairs neurobehavioral development by increasing reactive oxidative species production in Caenorhabditis elegans. Life Sci 319, 121500. https://doi.org/10.1016/j.lfs.2023.121500.
Hosomi, K., Kawashima, H., Nakano, A. et al. (2022). NanoSPECT imaging reveals the uptake of 123I-labeled oxidized low-density lipoprotein in the brown adipose tissue of mice via CD36. Cardiovasc Res, cvac167. https://doi.org/10.1093/cvr/cvac167.
Chang, C.-K., Chang, K.-H., Cheng, W.-C. et al. (2022). Lipid metabolomic signature might predict subclinical atherosclerosis in patients with active rheumatoid arthritis. Clin Exp Rheumatol. https://doi.org/10.55563/clinexprheumatol/int08c.
Lee, H.-C., Akhmedov, A. and Chen, C.-H. (2022). Spotlight on very-low-density lipoprotein as a driver of cardiometabolic disorders: Implications for disease progression and mechanistic insights. Front Cardiovasc Med 9, 993633. https://doi.org/10.3389/fcvm.2022.993633.
Lin, K.-C., Ting, L.-L., Chang, C.-L. et al. (2021). Ex vivo expanded circulating tumor cells for clinical anti-cancer drug prediction in patients with head and neck cancer. Cancers (Basel) 13, 6076. https://doi.org/10.3390/cancers13236076.
Tsai, M.-H., Chao, H.-R., Hsu, W.-L. et al. (2021). Analysis of polybrominated diphenyl ethers and lipid composition in human breast milk and their correlation with infant neurodevelopment. Int J Environ Res Public Health 18, 11501. https://doi.org/10.3390/ijerph182111501.
Chang, C.-K., Cheng, W.-C., Ma, W.-L. et al. (2021). The potential role of electronegative high-density lipoprotein H5 subfraction in RA-related atherosclerosis. Int J Mol Sci 22, 11419. https://doi.org/10.3390/ijms222111419.
Chang, C.-K., Chen, P.-K., Chen, C.-C. et al. (2021). Increased levels of omega-3 fatty acids and DHA are linked to pain reduction in rheumatoid arthritis patients treated with Janus kinase inhibitors. Nutrients 13, 3050. https://doi.org/10.3390/nu13093050.